Evidence map›Paper›PMID 41150430›Full record

ArticleVaccines2025

Serological Response to COVID-19 Vaccination in Saudi Arabia: A Comparative Study of IgG and Neutralising Antibodies Across Vaccine Platforms.

Mariam M AlEissa, Ahdab A Alsaieedi, Reema Alduaiji, Fahad Almsned, Yousif AlDossary, Nada Saleh, Raghad A AlQurashi, Esraa A Hawsa, Muath B Ben Shaded, Amer M Alshehri and 9 more

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Mariam M AlEissaCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Ahdab A AlsaieediDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Reema AlduaijiJohn Hopkins Aramco Healthcare, ARAMCO Saudi Arabia, Dhahran 31311, Saudi Arabia.
Fahad AlmsnedResearch Center, King Fahad Specialist Hospital in Dammam (KFSH-D), Dammam 32253, Saudi Arabia.ORCID 0000-0003-3421-1394
Yousif AlDossaryResearch Center, King Fahad Specialist Hospital in Dammam (KFSH-D), Dammam 32253, Saudi Arabia.
Nada SalehCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh 11481, Saudi Arabia.ORCID 0000-0003-3744-7378
Raghad A AlQurashiPublic Health Lab, Public Health Authority, Riyadh 11176, Saudi Arabia.
Esraa A HawsaPublic Health Lab, Public Health Authority, Riyadh 11176, Saudi Arabia.
Muath B Ben ShadedPublic Health Lab, Public Health Authority, Riyadh 11176, Saudi Arabia.
Amer M AlshehriPublic Health Lab, Public Health Authority, Riyadh 11176, Saudi Arabia.
Osamah T KhojahPathology Department, College of Medicine, King Saud University, Riyadh 12372, Saudi Arabia.ORCID 0000-0001-6641-4044
Eyad Y Abu SarhanMedical Diagnostic Laboratories, Sulaiman Alhabib Medical Group, Riyadh 12511, Saudi Arabia.
Hamad H AlonaziMinistry of Health, Riyadh 11176, Saudi Arabia.ORCID 0009-0008-4620-6553
Walid A NouhMedical Diagnostic Laboratories, Sulaiman Alhabib Medical Group, Riyadh 12511, Saudi Arabia.
Khalid H AlAnaziMinistry of Health, Riyadh 11176, Saudi Arabia.
Sami S AlmudrraGulf Center for Disease Prevention and Control, Gulf Health Council, Riyadh 11481, Saudi Arabia.ORCID 0000-0001-6653-9592
Khaled I AlAbdulkareemMinistry of Health, Riyadh 11176, Saudi Arabia.
Abdullah AlJurayyanImmunology and Serology Laboratory, Pathology and Clinical Laboratory Administration, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
Abdullah M AsiriCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19mRNA vaccineneutralising antibodiesSARS-CoV-2Saudi Arabiaserological responsevaccine immunogenicity

Identifiers

PMID41150430
PMCPMC12568187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.